“Dynamics into election look to be [a] perfect storm,” RBC analyst Brian Abrahams wrote, according to CNBC. “While GOP leaders do not see drug-pricing reform as a top priority, both [House Speaker Nancy] Pelosi and [President] Trump are very committed to having policy change. “
Mr. Abrahams said that the drug-pricing reform package is likely to be a “middle-of-the-road” policy change.
Escalating drug costs in the U.S. have become a major issue, with both Democrats and Republican lawmakers working on bills to curb costs. A bipartisan bill from Sens. Chuck Grassley, R-Iowa, and Ron Wyden, D-Ore., is making its way through the Senate.
Read the full report here.
More articles on pharmacy:
Pfizer to merge off-patent business with Mylan
Senate panel advances drug-pricing legislation
Average chief pharmacy officer salary by state
